by Eagle Analytical | May 29, 2020 | Blog, covid19, Eagle TV, Links
Shhh! Study Shows Talking May Spread COVID-19 A recent study conducted by the National Institute of Health (NIH) found that talking could present a risk for exposure to respiratory viruses, including the coronavirus. Droplets emitted when a person speaks can...
by Eagle Analytical | May 21, 2020 | Blog, covid19, Eagle Updates, Links
FDA Updates Guidance On Adverse Reporting During a Pandemic The FDA made an update to their final guidance, “Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic”. The guidance document now includes...
by Eagle Analytical | May 20, 2020 | Blog, Links
What It Means When Your Sample is Out-Of-Specification When sending samples for testing at third-party facilities, most clients want to ensure that results are both accurate and provided in a timely manner. This article intends to summarize the OOS process: With so...
by Eagle Analytical | May 15, 2020 | Blog, Links
Updates to FDA’s Purple Book: Database of Licensed Biological Products This week the FDA updated the Purple Book: Database of FDA-Licensed Biological Products. The update is part of a multi-phase enhancement of the database, intended to ultimately improve...
by Eagle Analytical | May 15, 2020 | Blog, covid19, Eagle Updates, Links
FDA Announces Update on MOU for Compounding Pharmacies On May 13, a standard memorandum of understanding, also known as a MOU, between the FDA and the states was made available for public viewing as part of the regulatory process. The article states that this marks a...
by Eagle Analytical | May 14, 2020 | Blog, covid19, Eagle Updates, Links
FDA Updates Temporary Policy Regarding PPE for Compounders The FDA has issued an update to its Temporary Policy Regarding Non-Standard PPE Practices for Pharmacy Compounders During the COVID-19 Pandemic. In the update, the FDA has clarified that drugs can be...
